Cue Biopharma, Inc. (CUE) vs ProQR Therapeutics N.V. (PRQR)
A side-by-side comparison of Cue Biopharma, Inc. and ProQR Therapeutics N.V. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CUE
Cue Biopharma, Inc.
$23.75HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
PRQR
ProQR Therapeutics N.V.
$1.65HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
Total return — CUE vs PRQR
growth of $100 · dividends reinvested · last 9yCUE -93.0% (-25.6%/yr)PRQR -49.4% (-7.3%/yr)PRQR compounded faster over this window
Log scale — wide-divergence pair
CUE PRQR
CUE vs PRQR: by the numbers
- •PRQR is the larger company ($173M vs $173M market cap).
- •Both run net losses; PRQR's is the smaller (-229.20% vs -435.83% net margin).
- •PRQR grew revenue faster over the past five years (94.34% vs 47.08% CAGR).
Metrics side by side
Valuation
| Metric | CUE | PRQR |
|---|---|---|
| P/S ratio | 4.58 | 8.06 |
| P/B ratio | 74.69 | 1.91 |
Profitability
| Metric | CUE | PRQR |
|---|---|---|
| Gross margin | 99.69% | 83.01% |
| Operating margin | -96.56% | -275.91% |
| Net margin | -435.83% | -229.20% |
| ROE | -7104.24% | -54.27% |
| ROIC | -1039.56% | -42.61% |
Growth (annualized)
| Metric | CUE | PRQR |
|---|---|---|
| Revenue CAGR (5Y) | 47.08% | 94.34% |
| Total return CAGR (5Y) | -42.42% | -26.23% |
Frequently asked
- Which has grown faster, CUE or PRQR?
- Over the past five years, PRQR grew revenue faster — CUE at a 47.08% CAGR versus PRQR at 94.34%.
- How have CUE and PRQR total returns compared?
- Over the past 5 years, CUE delivered -42.42% and PRQR delivered -26.23% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cue Biopharma ROEProQR Therapeutics ROECue Biopharma operating marginProQR Therapeutics operating marginCue Biopharma revenue growthProQR Therapeutics revenue growthCue Biopharma free cash flowProQR Therapeutics free cash flow
Cue Biopharma & ProQR Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.